Prediction of prokinetic agents in critically ill patients with feeding intolerance: a prospective observational clinical study [PDF]
Frontiers in Nutrition, 2023 BackgroundProkinetic agents are currently considered the first-line therapy to improve gastric emptying when feeding intolerance occurred in critically ill adults. In this study, we developed a technique to assess the feasibility of predicting prokinetic
Guangxuan Lv +14 more
doaj +4 more sources
Evaluation of prokinetic agents used in the treatment of gastroparesis [PDF]
Journal of Drug Assessment, 2017 Background/Aim: Hospitalizations due to gastroparesis have increased in the last 20 years with limited advancements in pharmacologic therapy. Although therapy primarily consists of prokinetic agents, little is known about their effects on hospital outcomes.
Jennifer Twilla
exaly +5 more sources
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022 Gastrointestinal (GI) prokinetic agents are drugs that increase GI motility and promote the movement of contents in the GI tract by amplifying and controlling the contraction of GI smooth muscle.
Hyo Yeop Song +2 more
doaj +2 more sources
Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study. [PDF]
PLoS ONE, 2021 BackgroundSome studies have indicated that the use of prokinetic agents may reduce pneumonia risk in some populations. Nasogastric tube insertion is known to increase the risk of pneumonia because it disrupts lower esophageal sphincter function.
Kun-Siang Huang +5 more
doaj +2 more sources
Efficacy and Safety of Mecobalamin Combined with Prokinetic Agents in the Treatment of Diabetic Gastroparesis: A Meta-Analysis [PDF]
Iranian Journal of Public Health, 2021 Background: The aim of the present study was to systematically review the efficacy and safety of mecobalamin combined with prokinetic agents in diabetic gastroparesis (DGP).
Jia Yao +5 more
doaj +2 more sources
A Meta-Analysis of the Efficacy of Prokinetic Agents against Glycemic Control [PDF]
Gastroenterology Research and Practice, 2019 Background. Prokinetic agents are used in diabetic gastroparesis patients to improve gastric emptying and upper gastrointestinal (GI) symptoms. However, the efficacy of prokinetic agents against glycemic control is questionable. Therefore, we conducted a
Yeon-Ji Kim +2 more
doaj +2 more sources
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects [PDF]
Frontiers in Pharmacology, 2021 Prokinetics is one of the therapeutic agents for functional and motility disorders of the stomach. However, its efficacy is limited. Kampo medicine is a unique medical system that was developed in Japan.
Kazumi Inokuchi +2 more
doaj +3 more sources
Efficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy – An open-label trial [PDF]
Caspian Journal of Internal Medicine, 2023 Background: It is pertinent to objectively assess the severity of diabetic gastroparesis and tailor treatment accordingly. The current study was planned to document gastroparesis by gastric emptying scintigraphy (GES) objectively and see the effect of ...
Ravi Kant +4 more
doaj +2 more sources
Symptom Overlap Stratifies Prokinetic Response in Functional Dyspepsia: A Real‐World Multicenter Study of 1297 Chinese Patients [PDF]
JGH OpenObjective Functional dyspepsia (FD) often overlaps with GERD‐, IBS‐, and FC‐like symptoms, complicating treatment. This study evaluated overlap patterns and their association with cinitapride response in Chinese FD patients.
Dan Zhou +5 more
doaj +2 more sources
Persistent Post-Traumatic Brain Injury Hiccups Unresponsive to Standard Agents: Resolution Associated With Levetiracetam Therapy. [PDF]
Clin Case RepABSTRACT Post‐traumatic hiccups are an uncommon but distressing complication of traumatic brain injury (TBI), often resistant to conventional pharmacological agents, and the underlying mechanism may involve central neurological disruption of inhibitory pathways rather than gastrointestinal or metabolic aetiologies. We report a male patient in his early
Karajeh R +4 more
europepmc +2 more sources